Research Area. Institute of Oncology Angel H. Roffo, University of Buenos Aires, Buenos Aires, Argentina.
Curr Pharm Biotechnol. 2011 Nov;12(11):1948-60. doi: 10.2174/138920111798376914.
Tumor metastasis is a main contributor to death in cancer patients. In the last years, a new class of molecules that reduces the metastatic propensity has been identified: metastasis suppressors. These proteins regulate multiple steps in the metastatic cascade, including cell invasion, survival in the vascular and lymphatic circulation, and colonization of distant organ sites. As a consequence, they are very important therapeutic targets. This review discusses our current understanding of metastasis suppressors and how this knowledge might be useful to improve the treatment of cancer patients.
肿瘤转移是癌症患者死亡的主要原因。在过去的几年中,人们发现了一类新的分子,它们可以降低转移倾向:转移抑制因子。这些蛋白质调节转移级联中的多个步骤,包括细胞侵袭、在血管和淋巴循环中的存活以及远处器官部位的定植。因此,它们是非常重要的治疗靶点。本文综述了我们目前对转移抑制因子的认识,以及这些知识如何有助于改善癌症患者的治疗。